文献速递神经MR

2HG与脂质乳酸比值较2HG浓度更能预测胶质瘤IDH突变状态

Comparative Value of 2-Hydroxyglutarate-to-Lipid and Lactate Ratio versus 2-Hydroxyglutarate Concentration on MR Spectroscopic Images for Predicting Isocitrate Dehydrogenase Mutation Status in Gliomas.
PubMed 文献 · Radiol Imaging Cancer · 2020-07-31

该回顾性研究纳入79例组织病理学证实的胶质瘤患者,术前采用单体素点分辨波谱测量2HG浓度及2HG/(脂质+乳酸)比值,比较两者预测IDH突变状态的效能。结果显示2HG/(脂质+乳酸)比值的AUC为0.90,优于2HG浓度的0.80,最佳截断值为0.63。

要点

  • 2HG/(脂质+乳酸)比值预测IDH突变的AUC为0.90,优于2HG浓度的0.80。
  • 2HG/(脂质+乳酸)比值最佳截断值为0.63,敏感度79%、特异度92%。

关键影像表现/征象

  • 2HG浓度预测IDH突变型胶质瘤的敏感度89%(25/28)、特异度67%(34/51)、AUC 0.80(95%CI 0.70,0.88)。
  • 2HG/(脂质+乳酸)比值预测IDH突变型胶质瘤的敏感度79%(22/28)、特异度92%(47/51)、AUC 0.90(95%CI 0.81,0.96)。

诊断标准与关键数值

  • 2HG/(脂质+乳酸)比值预测IDH突变型胶质瘤的最佳截断值为0.63,敏感度79%(22/28)、特异度92%(47/51)、AUC 0.90(95%CI 0.81,0.96)。
  • 2HG浓度预测IDH突变型胶质瘤的敏感度89%(25/28)、特异度67%(34/51)、AUC 0.80(95%CI 0.70,0.88)。

临床应用与阅片要点

  • 术前MR波谱测量2HG/(脂质+乳酸)比值有助于无创预测胶质瘤IDH突变状态。
  • 2HG/(脂质+乳酸)比值特异度较高(92%),可减少IDH野生型的误判。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the ability of 2-hydroxyglutarate (2HG)-to-lipid and lactate (2HG/[lipid + lactate]) ratio with the ability of 2HG concentration alone to predict the isocitrate dehydrogenase (IDH) mutation status in patients with glioma.

MATERIALS AND METHODS: In this retrospective study, consecutive patients with histopathologically proven glioma were enrolled between July 2016 and February 2019. A total of 79 patients were enrolled (mean age, 44 years; 49 men). The 2HG concentration and other MR spectroscopic parameters were measured by single-voxel point-resolved spectroscopy before surgery. The diagnostic performance of the 2HG concentration and 2HG/(lipid + lactate) ratio were calculated. Internal validation was assessed by the bootstrap approach with 1000 bootstrap resamples. Differences in the predictive accuracy of 2HG/(lipid + lactate) ratio and 2HG concentration were determined by calculating the integrated discrimination improvement. The diagnostic accuracy (sensitivity, specificity, and area under the receiver operating characteristic curve [AUC]) of these measures was also compared separately in patients with glioblastomas and patients with lower-grade gliomas.

RESULTS: Of the 79 enrolled patients, 28 had IDH mutations and 51 had wild-type IDH. The sensitivity, specificity, and AUC of 2HG concentration for predicting IDH-mutant gliomas were 89% (25 of 28), 67% (34 of 51), and 0.80 (95% confidence interval [CI]: 0.70, 0.88; C statistic, 0.80), respectively. The sensitivity, specificity, and AUC of the 2HG/(lipid + lactate) ratio for predicting IDH-mutant gliomas were 79% (22 of 28), 92% (47 of 51), and 0.90 (95% CI: 0.81, 0.96; C statistics, 0.90), respectively. The optimal cutoff value for the 2HG/(lipid + lactate) ratio was 0.63. The 2HG/(lipid + lactate) ratio was significantly better for predicting IDH mutation status than the 2HG concentration alone (P < .01). In glioblastoma, the 2HG/(lipid + lactate) ratio was also better for predicting IDH mutations than the 2HG concentration alone, with borderline significance (P = .052). In lower-grade glioma, the 2HG/(lipid + lactate) ratio and the 2HG concentration showed comparable diagnostic performance (P = .72).

CONCLUSION: The 2HG/(lipid + lactate) ratio is more accurate for predicting IDH mutation status in patients with glioma than the 2HG concentration alone.Keywords: Brain/Brain Stem, CNS, MR-Imaging, MR-Spectroscopy, Neoplasms-Primary, Neuro-Oncology© RSNA, 2020.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Suh CH, Kim HS, Park JE, et al. Comparative Value of 2-Hydroxyglutarate-to-Lipid and Lactate Ratio versus 2-Hydroxyglutarate Concentration on MR Spectroscopic Images for Predicting Isocitrate Dehydrogenase Mutation Status in Gliomas. Radiol Imaging Cancer. 2020. PMID: 33778723. doi:10.1148/rycan.2020190083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。